Sanofi ADR
Price & Volume
Stats
See more52W Range | $43.85-$57.56 |
Market Cap | $121.1B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $45.9B |
Revenue Growth (YoY) | -7% |
Gross Profit (12 Mos) | $33B |
Diluted EPS | $3.02 |
News
See moreYahoo Finance • 12 hours ago
EU approves Sanofi and Regeneron’s Dupixent as first targeted therapy for chronic spontaneous urticaria in a decade
Yahoo Finance • 15 hours ago
Sanofi And Regeneron : European Commission Approves Dupixent For CSU In Adults And Adolescents
Yahoo Finance • 16 hours ago
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Yahoo Finance • yesterday
Top pharmaceutical stocks by Quant to focus on as Novo Nordisk slides
About
CEO | Mr. Paul Hudson |
CFO | Mr. François-Xavier Roger |
Address | 46, avenue de la Grande Armée, Paris, France, 75017 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 82,878 |
